INS and diabetes mellitus: Currently, there is no cure for DM; therefore, pharmacological management aims to either enhance endogenous insulin secretion (e.g., sulphonylureas) or improve insulin sensitivity (e.g., thiazolidinediones and the biguanide metformin).